PEDIATRIX MEDICAL GROUP INC (MD) Stock Overview
NYSE:MD - US58502B1061 - Common Stock
MD Key Statistics, Chart & Performance
The current stock price of MD is 17.21 USD. In the past month the price increased by 43.66%. In the past year, price increased by 58.47%.
MD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.54 | 92.78B | ||
| CI | THE CIGNA GROUP | 10.71 | 80.31B | ||
| LH | LABCORP HOLDINGS INC | 18.36 | 23.10B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.2 | 20.31B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 12.6 | 15.08B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.31 | 14.46B | ||
| DVA | DAVITA INC | 14.22 | 9.85B | ||
| HIMS | HIMS & HERS HEALTH INC | 52.94 | 9.57B | ||
| GH | GUARDANT HEALTH INC | N/A | 8.41B | ||
| CHE | CHEMED CORP | 20.47 | 6.67B | ||
| RDNT | RADNET INC | 199.33 | 5.52B | ||
| OPCH | OPTION CARE HEALTH INC | 21.24 | 4.65B |
Related stock screener links
About MD
Company Profile
Pediatrix Medical Group, Inc. engages in the provision of physician services. The company is headquartered in Sunrise, Florida and currently employs 2,150 full-time employees. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by pediatric subspecialties. The company offers specialized and critical care services through approximately 4,400 affiliated physicians and other clinicians. The company provides neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The firm provides maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.
Company Info
PEDIATRIX MEDICAL GROUP INC
1301 Concord Terrace
Sunrise FLORIDA 33323 US
CEO: Mark S. Ordan
Employees: 4120
Phone: 19543840175
PEDIATRIX MEDICAL GROUP INC / MD FAQ
What is the stock price of PEDIATRIX MEDICAL GROUP INC today?
The current stock price of MD is 17.21 USD. The price increased by 0.64% in the last trading session.
What is the ticker symbol for PEDIATRIX MEDICAL GROUP INC stock?
The exchange symbol of PEDIATRIX MEDICAL GROUP INC is MD and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is MD stock listed?
MD stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for PEDIATRIX MEDICAL GROUP INC stock?
16 analysts have analysed MD and the average price target is 17.05 USD. This implies a price decrease of -0.94% is expected in the next year compared to the current price of 17.21. Check the PEDIATRIX MEDICAL GROUP INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PEDIATRIX MEDICAL GROUP INC worth?
PEDIATRIX MEDICAL GROUP INC (MD) has a market capitalization of 1.50B USD. This makes MD a Small Cap stock.
How many employees does PEDIATRIX MEDICAL GROUP INC have?
PEDIATRIX MEDICAL GROUP INC (MD) currently has 4120 employees.
What are the support and resistance levels for PEDIATRIX MEDICAL GROUP INC (MD) stock?
PEDIATRIX MEDICAL GROUP INC (MD) has a support level at 12.35. Check the full technical report for a detailed analysis of MD support and resistance levels.
Is PEDIATRIX MEDICAL GROUP INC (MD) expected to grow?
The Revenue of PEDIATRIX MEDICAL GROUP INC (MD) is expected to decline by -5.69% in the next year. Check the estimates tab for more information on the MD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy PEDIATRIX MEDICAL GROUP INC (MD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MD, evaluating the profitability, health, valuation and growth aspects
- PEDIATRIX MEDICAL GROUP INC (MD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PEDIATRIX MEDICAL GROUP INC (MD) Sales and EPS estimates to see what analysts future expectations are.
- PEDIATRIX MEDICAL GROUP INC (MD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PEDIATRIX MEDICAL GROUP INC (MD) Insider and Institutional Ownership to learn about the owners and their transactions.
- PEDIATRIX MEDICAL GROUP INC (MD) Stock Chart to make your own analysis
- PEDIATRIX MEDICAL GROUP INC (MD) Latest news and press-releases to stay up to date.
Does PEDIATRIX MEDICAL GROUP INC (MD) stock pay dividends?
MD does not pay a dividend.
When does PEDIATRIX MEDICAL GROUP INC (MD) report earnings?
PEDIATRIX MEDICAL GROUP INC (MD) will report earnings on 2025-10-30, before the market open.
What is the Price/Earnings (PE) ratio of PEDIATRIX MEDICAL GROUP INC (MD)?
The PE ratio for PEDIATRIX MEDICAL GROUP INC (MD) is 9.51. This is based on the reported non-GAAP earnings per share of 1.81 and the current share price of 17.21 USD. Check the full fundamental report for a full analysis of the valuation metrics for MD.
What is the Short Interest ratio of PEDIATRIX MEDICAL GROUP INC (MD) stock?
The outstanding short interest for PEDIATRIX MEDICAL GROUP INC (MD) is 2.15% of its float. Check the ownership tab for more information on the MD short interest.
MD Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to MD. When comparing the yearly performance of all stocks, MD is one of the better performing stocks in the market, outperforming 89.62% of all stocks.
MD Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to MD. MD has an average financial health and profitability rating.
MD Financial Highlights
Over the last trailing twelve months MD reported a non-GAAP Earnings per Share(EPS) of 1.81. The EPS increased by 53.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.66% | ||
| ROA | 5.23% | ||
| ROE | 13.18% | ||
| Debt/Equity | 0.7 |
MD Forecast & Estimates
16 analysts have analysed MD and the average price target is 17.05 USD. This implies a price decrease of -0.94% is expected in the next year compared to the current price of 17.21.
For the next year, analysts expect an EPS growth of 24.34% and a revenue growth -5.69% for MD